Anifrolumab (Saphnelo) listed in MB
March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024.
For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf